Sources | Names Used |
---|---|
CTRPv2 | BRD-A02303741:navitoclax (2:1 mol/mol) |
PharmacoGx | BRD-A02303741:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SBK1 | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-12 |
mRNA | MYT1L | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-11 |
mRNA | TMOD2 | CTRPv2 | pan-cancer | AAC | 0.27 | 8e-11 |
mRNA | GMFG | CTRPv2 | pan-cancer | AAC | 0.27 | 3e-08 |
mRNA | KIAA1147 | CTRPv2 | pan-cancer | AAC | 0.27 | 1e-13 |
mRNA | CRMP1 | CTRPv2 | pan-cancer | AAC | 0.27 | 3e-11 |
mRNA | RP11-729L2.2 | CTRPv2 | pan-cancer | AAC | 0.27 | 3e-12 |
mRNA | ZNF737 | CTRPv2 | pan-cancer | AAC | 0.28 | 8e-14 |
mRNA | CELF4 | CTRPv2 | pan-cancer | AAC | 0.28 | 6e-14 |
mRNA | MYB | CTRPv2 | pan-cancer | AAC | 0.28 | 5e-10 |